| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 259, Issue 5 1433-H1439, Copyright © 1990 by American Physiological Society
ARTICLES |
V. Richard, F. C. Tanner, M. Tschudi and T. F. Luscher
Department of Research, University Hospital, Basel, Switzerland.
Endothelial cells release nitric oxide from L-arginine, and this pathway can be inhibited by the analogue of L-arginine, NG-monomethyl-L-arginine (L-NMMA). The effect of L-NMMA on endothelium-dependent relaxation of epicardial porcine coronary arteries was studied in isolated blood vessels suspended in organ chambers for isometric tension recording. Endothelium-dependent relaxations to bradykinin, serotonin, and the alpha 2-adrenergic agonist clonidine were evaluated in the presence and absence of L-NMMA (10(-5)-10(-3) M). L-NMMA, as well as the inhibitor of guanylate cyclase methylene blue (10(-5) M) and hemoglobin (10(-5) M), inhibited endothelium-dependent relaxation to serotonin and clonidine. The effect of L-NMMA could be reversed by L-arginine but not by D-arginine. In contrast, L-NMMA, methylene blue, and hemoglobin caused a weak inhibition of the endothelium-dependent relaxation evoked by bradykinin; indomethacin and tranylcypromine had no effect. The inhibitor of Gi proteins pertussis toxin (100 ng/ml) abolished the relaxations evoked by clonidine and markedly reduced those evoked by serotonin but did not affect those caused by bradykinin. In the presence of pertussis toxin, L-NMMA induced a further reduction of the relaxations to serotonin, suggesting that inhibition of Gi proteins does not completely prevent the activation of the L-arginine pathway. Thus endothelium-dependent relaxations to serotonin and to the alpha 2-adrenergic agonist clonidine are mediated through the release of nitric oxide formed from L-arginine in endothelial cells, whereas bradykinin evokes endothelium-dependent relaxations via a different pathway.
This article has been cited by other articles:
|
|
 |
|
  T. Kobayashi, T. Matsumoto, K. Ooishi, and K. Kamata Differential expression of {alpha}2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H135 - H148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. V. Dantas, J. Igarashi, and T. Michel Sphingosine 1-phosphate and control of vascular tone Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2045 - H2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Carter, M. Begaye, and N. L. Kanagy Acute and chronic NOS inhibition enhances alpha 2- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1361 - H1369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Plato and J. L. Garvin alpha 2-Adrenergic-mediated tubular NO production inhibits thick ascending limb chloride absorption Am J Physiol Renal Physiol, October 1, 2001; 281(4): F679 - F686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Grieve, P. A. MacCarthy, N. P. Gall, A. C. Cave, and A. M. Shah Divergent Biological Actions of Coronary Endothelial Nitric Oxide During Progression of Cardiac Hypertrophy Hypertension, August 1, 2001; 38(2): 267 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yang, E. Scalbert, P. Delagrange, P. M. Vanhoutte, and S. T. O'Rourke Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H76 - H82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-P. Zou and A. W. Cowley Jr. alpha 2-Adrenergic receptor-mediated increase in NO production buffers renal medullary vasoconstriction Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R769 - R777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.F. WATTS, S. HERRMANN, and F.M. RICHES Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men QJM, March 1, 2000; 93(3): 153 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Thollon, J. P. Bidouard, C. Cambarrat, I. Delescluse, N. Villeneuve, P. M. Vanhoutte, and J. P. Vilaine Alteration of Endothelium-Dependent Hyperpolarizations in Porcine Coronary Arteries With Regenerated Endothelium Circ. Res., March 5, 1999; 84(4): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. Campbell and D. R. Harder Endothelium-Derived Hyperpolarizing Factors and Vascular Cytochrome P450 Metabolites of Arachidonic Acid in the Regulation of Tone Circ. Res., March 5, 1999; 84(4): 484 - 488. [Full Text] [PDF]
|
|
|
|
|
|
M. Camacho, J. Lopez-Belmonte, and L. Vila Rate of Vasoconstrictor Prostanoids Released by Endothelial Cells Depends on Cyclooxygenase-2 Expression and Prostaglandin I Synthase Activity Circ. Res., August 24, 1998; 83(4): 353 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Hein and L. Kuo LDLs Impair Vasomotor Function of the Coronary Microcirculation : Role of Superoxide Anions Circ. Res., August 24, 1998; 83(4): 404 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Nase and M. A. Boegehold Postjunctional alpha 2-adrenoceptors are not present in proximal arterioles of rat intestine Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H202 - H208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Node, M. Kitakaze, H. Kosaka, T. Minamino, and M. Hori Bradykinin Mediation of Ca2+-Activated K+ Channels Regulates Coronary Blood Flow in Ischemic Myocardium Circulation, March 18, 1997; 95(6): 1560 - 1567. [Abstract] [Full Text]
|
|
|
|
|
|
T. Komaru, T. Tanikawa, A. Sugimura, T. Kumagai, K. Sato, H. Kanatsuka, and K. Shirato Mechanisms of Coronary Microvascular Dilation Induced by the Activation of Pertussis Toxin–Sensitive G Proteins Are Vessel-Size Dependent: Heterogeneous Involvement of Nitric Oxide Pathway and ATP-Sensitive K+ Channels Circ. Res., January 1, 1997; 80(1): 1 - 10. [Abstract] [Full Text]
|
|
|
|
|
|
L. Puybasset, M.-L. Bea, B. Ghaleh, J.-F. Giudicelli, and A. Berdeaux Coronary and Systemic Hemodynamic Effects of Sustained Inhibition of Nitric Oxide Synthesis in Conscious Dogs: Evidence for Cross Talk Between Nitric Oxide and Cyclooxygenase in Coronary Vessels Circ. Res., August 1, 1996; 79(2): 343 - 357. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kadokami, K. Egashira, K. Kuwata, Y. Fukumoto, T. Kozai, H. Yasutake, T. Kuga, H. Shimokawa, K. Sueishi, and A. Takeshita Altered Serotonin Receptor Subtypes Mediate Coronary Microvascular Hyperreactivityin Pigs With Chronic Inhibitionof Nitric Oxide Synthesis Circulation, July 15, 1996; 94(2): 182 - 189. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Cohen and P. M. Vanhoutte Endothelium-Dependent Hyperpolarization : Beyond Nitric Oxide and Cyclic GMP Circulation, December 1, 1995; 92(11): 3337 - 3349. [Full Text]
|
|
|
|
|
|
A. Ito, K. Egashira, T. Kadokami, Y. Fukumoto, T. Takayanagi, R. Nakaike, T. Kuga, K. Sueishi, H. Shimokawa, and A. Takeshita Chronic Inhibition of Endothelium-Derived Nitric Oxide Synthesis Causes Coronary Microvascular Structural Changes and Hyperreactivity to Serotonin in Pigs Circulation, November 1, 1995; 92(9): 2636 - 2644. [Abstract] [Full Text]
|
|
|
|
|
|
R. Joannides, W. E. Haefeli, L. Linder, V. Richard, E. H. Bakkali, C. Thuillez, and T. F. Luscher Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo Circulation, March 1, 1995; 91(5): 1314 - 1319. [Abstract] [Full Text]
|
|
|
|
|
|
C. F. Kung and T. F. Luscher Different Mechanisms of Endothelial Dysfunction With Aging and Hypertension in Rat Aorta Hypertension, February 1, 1995; 25(2): 194 - 200. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
